Next Generation Cancer Clinical Trials
October 13 - 16, 2017
Abstract Deadline: August 11, 2017


Elizabeth Jaffee, Johns Hopkins University
Robert Maki, Northwell Health
David Tuveson,
Cold Spring Harbor Laboratory

You are cordially invited to participate in the first meeting on Next Generation Cancer Clinical Trials to be held October 13-15, 2017 at Cold Spring Harbor Laboratory. The goals of the meeting are to highlight recent clinical therapeutic and diagnostic advances, and to productively discuss the emerging scientific and logistical obstacles that hinder dramatic improvements in patient outcome.  The meeting will include keynote speakers, invited talks by discussion leaders, talks selected from abstracts, posters and two discussion forums.

The meeting will start with a joint keynote session on Friday afternoon at 4pm October 13 (shared with the Biology of Cancer: Microenvironment & Metastasis meeting as part of CSHL's Cancer Week), an opening reception and conference dinner, followed by two full days of program on October 14 and 15. Departures on Monday morning.

Keynote Speakers (Joint Conference Session Friday 4pm):
Thomas Lynch, CSO, Bristol-Myers Squibb
Elaine Mardis, Nationwide Children's Hospital Research Institute
Joan Massague, Memorial Sloan Kettering Cancer Center

Keynote Speaker (Sunday 4:30 pm
Irving Weissman, Stanford University

  • Diagnostics and Therapeutics
  • Forum I - Big Data
  • Therapeutics
  • Therapeutics
  • Forum II - The Ecosystem of Cancer Drug Discovery
  • Immunology
Discussion Leaders:
Alberto Bardelli, University of Torino School of Medicine, Italy
Peter Dirks, Hospital for Sick Children, University of Toronto, Canada
Jennifer Grandis, University of California, San Francisco
Elizabeth Jaffee, Johns Hopkins University
Rakesh Jain, Massachusetts General Hospital
Dung T. Le, Sidney Kimmel Comprehensive Cancer Center
Sanford Markowitz, Case Wesern Reserve University
Martin Pomper, Johns Hopkins School of Medicine
Kanti Rai, Feinstein Institute for Medical Research, Northwell Health
Lillian Siu, Princess Margaret Hospital, Canada
Louis Staudt, National Cancer Institute
Kimberly Stegmaier, Dana-Farber Cancer Institute
Suzanne Topalian, Johns Hopkins University
Paul Workman, The Institute of Cancer Research UK, London, UK

Please bring this notice to the attention of any of your colleagues who may be interested in participating in the meeting.

All abstracts must be submitted by the abstract deadline. The status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We have applied for funds from government and industry to partially support graduate students and postdocs. Please apply in writing via email to Val Pakaluk and state your financial needs; preference will be given to those who submit abstracts.

Social Media
The designated hashtag for this meeting is #cshlclinonc. Note that you must obtain permission from an individual presenter before live-tweeting or discussing his/her talk, poster, or research results on social media. Click the Policies tab above to see our full Confidentiality & Reporting Policy.

We look forward to seeing you at Cold Spring Harbor in October.

Major support for this meeting is generously provided by Northwell Health.

Academic Package $1,165
Graduate/PhD Student Package $975
Corporate Package $1,475
Academic/Student No-Housing Package $795
Corporate No-Housing Package $995

Participants registering for both the Biology of Cancer: Microenvironment & Metastasis meeting and the Next Generation Cancer Clinical Trials meeting are eligible for a 15% discount on their total fee. Please notify Val Pakaluk if you have registered for both meetings

Regular packages are all-inclusive and cover registration, food, housing, parking, a wine-and-cheese reception, and lobster banquet. No-Housing packages include all costs except housing. Full payment is due four weeks prior to the meeting.